All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

NEWSROOM

Corporate

05/06/2023

Fidia Farmaceutici, 11% growth in 2022: turnover of €412 million

Our Focus

31/03/2023

Fidia Farmaceutici wins ‘2023 Best Aesthetic Regenerative Medicine product’ Award

Corporate

10/02/2023

Fidia Farmaceutici enters the Polish market

Corporate

09/06/2022

2021 Financial Statements: Fidia Farmaceutici achieves double-digit growth, with EBITDA exceeding 20% of turnover